Enoxaparin Sodium Injection IP

Product Description

1. Product Description

It is administered via subcutaneous injection by medical professionals in hospitals or clinical settings. It is not meant for self-administration. Due to our expertise in this domain, we are engaged in offering Enoxaparin Sodium Injection IP which is an anticoagulant (blood thinner) used to prevent blood clots that are sometimes called deep vein thrombosis (DVT), which can lead to blood clots in the lungs. Our injection is checked on different quality parameters under the guidance of our knowledgeable quality controller. This Enoxaparin Sodium Injection IP is available in different packaging options in order to fulfill their exact demands of our customer.

2. Technical Specifications

3. Product Highlights

Generic Name: Enoxaparin Sodium

Strength: 40mg in 0.4mL solution

Dosage Form: Injectable anticoagulant solution

Packaging Type: Prefilled syringe in individual carton

Therapeutic Category: Anticoagulant / LMWH

Application Area: Preventive and treatment use for systemic venous thromboembolism

Formulation: Sterile solution

Storage Conditions:

• Store below 25C

• Protect from light and moisture

• Keep in original packaging and out of reach of children

4. Therapeutic Uses

• Prevention and treatment of deep vein thrombosis (DVT)

• Preventing pulmonary embolism (PE)

• Prophylaxis and treatment of thromboembolic events in medical and surgical patients, including after surgeries (e.g., orthopedic, abdominal)

• May support implantation and miscarriage prevention in IVF-related scenarios where clotting is a risk factor

5. Safety Profile & Side Effects

• Bleeding (from minor bruises to serious internal hemorrhage)

• Injection-site reactions (pain, bruising, erythema)

• Headache, dizziness

• Elevated liver enzymes, thrombocytopenia (low platelet count)

• Fever, anemia, peripheral edema, nausea, diarrhea, confusion

• Major bleeding events (e.g. gastrointestinal, intracranial)

• Severe anemia, significant liver injury

6. Precautions

• Prescription-only medication must be administered by qualified healthcare professionals

• Contraindicated in active bleeding, untreated hemorrhagic disorders, severe kidney or liver disease, recent stroke, or history of heparininduced thrombocytopenia (HIT)

• Use with caution in patients with liver dysfunction, renal impairment, low body weight, hypertension, or diabetes

• Avoid concomitant use with other anticoagulants or drugs that increase bleeding risk (e.g., warfarin, NSAIDs like naproxen or ibuprofen, thrombolytics) unless under close medical supervision

• Monitor CBC (platelet count), liver and kidney function periodically

• Inform medical provider if pregnant or breastfeeding; discontinue use if significant bleeding occurs

• Advise patients to avoid alcohol, be cautious with sharp objects, and report any signs of unusual bleeding